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This study aimed to evaluate the subclinical gait abnormalities and the postoperative gait 
improvements in patients with degenerative cervical myelopathy using three‑dimensional gait 
analysis. We reviewed the gait analysis of 62 patients who underwent surgical treatment for 
degenerative cervical myelopathy. The asymptomatic gait group included 30 patients and the gait 
disturbance group included 32 patients who can walk on their own slowly or need assistive device on 
stairs. The step width (17.2 cm vs. 15.9 cm, P = 0.003), stride length (105.2 cm vs. 109.1 cm, P = 0.015), 
and double‑limb support duration (13.4% vs. 11.7%, P = 0.027) improved only in the asymptomatic 
gait group. Preoperatively, the asymptomatic gait group exhibited better maximum knee flexion 
angle (60.5° vs. 54.8°, P = 0.001) and ankle plantarflexion angle at push‑off (− 12.2° vs. − 6.5°, 
P = 0.001) compared to the gait disturbance group. Postoperatively, maximum knee flexion angle 
(62.3° vs. 58.2°, P = 0.004) and ankle plantarflexion angle at push‑off (− 12.8° vs. − 8.3°, P = 0.002) 
were still better in the asymptomatic gait group, although both parameters improved in the gait 
disturbance group (P = 0.005, 0.039, respectively). Kinematic parameters could improve in patients 
with gait disturbance. However, temporospatial parameters improvement may be expected when the 
operative treatment is performed before apparent gait disturbance.
Various degenerative conditions of the cervical spine, including cervical spondylotic myelopathy, degenera-
tive disc disease, and ossification of the posterior longitudinal ligament and ligamentum flavum can result in 
degenerative cervical myelopathy (DCM)1. There are several manifestations of DCM, including clumsy hands, 
paresthesia, neck pain, and gait  disturbances2. Gait disturbances in DCM are caused by a spinal cord impair-
ment lesion; the severity of gait disturbance is diverse and should be systematically examined, as they could be 
misunderstood as a symptom of lumbar spinal  disease3–5. However, functional scales (GRASSP-M, Nurick, and 
JOA) designed to evaluate disability in patients with DCM provide only qualitative information of gait disabil-
ity, rather than quantitative assessment, and may not be sensitive to less pronounced gait changes since a single 
category often encompasses a wide range of severities or do not include gait  abnormality6–8.
Three-dimensional gait analysis can provide detailed and quantifiable information about gait parameters. 
Previous studies suggested slow walking speed or reduced joint range of motion (ROM) as pathologic gait param-
eters in DCM, and reported an improvement of gait parameters after  operation9–11. However, the decrease in 
gait parameters was diverse, and Malone et al. found that temporospatial or other kinematic parameters showed 
no improvement after  operation9,12. This inconsistent result may be related to the different severity of DCM in 
terms of gait disturbance. Patients may have only upper extremity symptoms and may not be aware of their gait 
disability, or the severely affected gait disturbance may not improve after  operation2,13,14. Identifying quantitative 
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gait differences in patients with DCM would contribute to the detection of subtle preoperative impairments and 
help predict postoperative improvements.
In this study, we reviewed pre- and postoperative gait analysis of DCM patients who had gait disturbance and 
those without gait symptoms. The current study aimed to evaluate (1) preoperative subclinical gait abnormalities 
in patients with DCM and (2) the improvements in gait parameters after surgery using three-dimensional gait 
analysis in patients with and without apparent gait abnormality.
Results
Participants. Between asymptomatic gait and gait disturbance groups, there was no difference in the age at 
surgery (61.4 ± 10.8 years vs. 55.1 ± 9.0 years, P = 0.437), duration of preoperative symptoms (11.5 ± 4.3 months 
vs. 12.3 ± 5.1 months, P = 0.553), and anterior/posterior operation (19/11 vs. 21/11, P = 0.53). Both pre- (14.6 ± 1.9 
vs. 11.6 ± 2.3) and postoperative (15.1 ± 1.7 vs. 12.4 ± 3.0) JOA scores were higher in the asymptomatic gait group 
(Table 1). JOA scores improved significantly after surgery in both groups (P = 0.013 for asymptomatic gait and 
P = 0.016 for gait disturbance group). However, there was no significant change in lower limb motor function 
grade according to JOA (P = 0.083 for asymptomatic gait and P = 0.231 for gait disturbance group).
Comparison of temporospatial parameters between groups. Preoperatively, patients in the gait dis-
turbance group exhibited a shorter stride length (105.2 ± 11.5 cm vs. 94.2 ± 23.4 cm, P = 0.001) and a slower walk-
ing speed (93.9 ± 13.6 cm/s vs. 81.5 ± 24.9 cm/s, P = 0.001), in addition to their longer standing phase duration 
(61.8 ± 4.6% vs. 64.2 ± 5.7%, P = 0.001) and double-limb support duration (13.4 ± 3.7% vs. 16.1 ± 7.3%, P = 0.011), 
compared to the asymptomatic gait group. However, there was no difference in the step width (17.2 ± 3.4 cm vs. 
17.4 ± 2.4 cm, P = 0.553).
Postoperatively, patients in the gait disturbance group continued to have a shorter stride length 
(109.1 ± 15.2 cm vs. 97.2 ± 23.7 cm, P = 0.001) and slower walking speed (96.7 ± 22.1 cm/s vs. 85.3 ± 24.9 cm/s, 
P = 0.008) with longer standing phase duration (61.3 ± 3.2% vs. 63.3 ± 3.9%, P = 0.003) and double-limb support 
duration (11.7 ± 4.3% vs. 14.8 ± 9.2%, P = 0.016). Furthermore, postoperative step width became longer compared 
to the asymptomatic gait group (15.9 ± 3.4 cm vs. 18.7 ± 8.8 cm, P = 0.021) (Table 2).
Table 1.  Patient characteristics of asymptomatic gait and gait disturbance groups. JOA Japanese Orthopedic 
Association. *P < 0.05.
Characteristics Asymptomatic gait Gait disturbance P value
Age (years) 61.4 ± 10.8 55.1 ± 9.0 0.437
Duration of symptoms before surgery (months) 11.5 ± 4.3 12.3 ± 5.1 0.553
Sex (Male:Female) 22:8 24:8 0.162
Body mass index (kg/m2) 27.4 ± 6.5 27.8 ± 10.8 0.860
JOA scores
Preoperative 14.6 ± 1.9 11.6 ± 2.3 0.001*





Table 2.  Comparison of temporospatial parameters between asymptomatic gait and gait disturbance groups. 
*P < 0.05.
Parameters Asymptomatic gait Gait disturbance P value
Preoperative
Step width (cm) 17.2 ± 3.4 17.4 ± 2.4 0.553
Stride length (cm) 105.2 ± 11.5 94.2 ± 23.4 0.001*
Velocity (cm/s) 93.9 ± 13.6 81.5 ± 24.9 0.001*
Duration of standing phase (% of gait cycle) 61.8 ± 4.6 64.2 ± 5.7 0.001*
Duration of double-limb support (% of gait cycle) 13.4 ± 3.7 16.1 ± 7.3 0.011*
Postoperative
Step width (cm) 15.9 ± 3.4 18.7 ± 8.8 0.021*
Stride length (cm) 109.1 ± 15.2 97.2 ± 23.7 0.001*
Velocity (cm/s) 96.7 ± 22.1 85.3 ± 24.9 0.008*
Duration of standing phase (% of gait cycle) 61.3 ± 3.2 63.3 ± 3.9 0.003*
Duration of double-limb support (% of gait cycle) 11.7 ± 4.3 14.8 ± 9.2 0.016*
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Changes in temporospatial parameters. In the asymptomatic gait group, step width (17.2 ± 3.4 cm vs. 
15.9 ± 3.4  cm, P = 0.003) and double-limb support duration (13.4 ± 3.7% vs. 11.7 ± 4.3%, P = 0.027) decreased 
after surgery, whereas stride length increased significantly (105.2 ± 11.5 cm vs. 109.1 ± 15.2 cm, P = 0.015). There 
were no changes in velocity (P = 0.317) and duration of the standing phase (P = 0.552).
However, in the gait disturbance group, temporospatial parameters did not improve postoperatively (P = 0.225, 
0.119, 0.107, 0.257, and 0.355 for step width, stride length, velocity, duration of the standing phase, and duration 
of double-limb support duration, respectively).
Comparison of kinetic and kinematic parameters between groups. Preoperatively, the gait dis-
turbance group had a declined maximum knee flexion angle during the swing phase (60.5 ± 6.4° vs. 54.8 ± 9.5°, 
P = 0.001) and ankle plantarflexion angle at push-off (− 12.2 ± 7.4° vs. − 6.5 ± 6.5°, P = 0.001) compared to the 
asymptomatic gait group (Table 3).
After surgery, the gait disturbance group still demonstrated a less maximum knee flexion angle during the 
swing phase (62.3 ± 5.4° vs. 58.2 ± 9.7°, P = 0.004) and ankle plantarflexion angle at push-off (− 12.8 ± 8.2° vs. 
− 8.3 ± 8.1°, P = 0.002) compared to the asymptomatic gait group (Table 4).
Changes in kinetic and kinematic parameters. In the asymptomatic gait group, there were no sig-
nificant changes in the mean pelvic anterior tilt (P = 0.066), maximum hip extension angle (P = 0.625), maxi-
mum knee flexion angle (P = 0.062), maximum ankle moment (P = 0.798), and maximum ankle power gen-
eration (P = 0.287). However, the ankle plantarflexion angle at push-off increased significantly (− 12.2 ± 7.4° vs. 
− 12.8 ± 8.2°, P = 0.042).
In the gait disturbance group, the mean pelvic anterior tilt (9.9 ± 8.2° vs. 11.6 ± 7.7°, P = 0.028) increased and 
the maximum hip extension angle decreased (− 2.9 ± 13.9° vs. 0.7 ± 16.2°, P = 0.006) after surgery. The maximum 
knee flexion angle (54.8 ± 9.5° vs. 58.2 ± 9.7°, P = 0.005) and the ankle plantarflexion angle at push-off (− 6.5 ± 6.5° 
vs. − 8.3 ± 8.1°, P = 0.039) increased significantly. After surgery, the maximum ankle moment increased signifi-
cantly (0.9 ± 0.4 Nm/kg vs. 0.9 ± 0.3 Nm/kg, P = 0.024), whereas the maximum ankle power generation (P = 0.583) 
remained unchanged.
In both groups, the ankle plantarflexion at initial contact was noted preoperatively (− 3.0 ± 4.3° in asympto-
matic gait group vs. − 2.6 ± 3.7° in gait disturbance group, P=0.502) and postoperatively (− 3.6 ± 3.9° in asymp-
tomatic gait group vs. − 2.7 ± 4.1° in gait disturbance group, P=0.205) (Figure 1). This ankle plantarflexion at 
initial contact did not change in both the asymptomatic gait (P=0.377) and the gait disturbance (P=0.851) groups 
by operation.
Table 3.  Comparison of preoperative kinetic and kinematic parameters between groups. Negative values 
indicate hip extension and ankle plantarflexion. *P < 0.05.
Parameters Asymptomatic gait Gait disturbance P value
Kinematics (°)
Mean pelvic anterior tilt angle 9.0 ± 6.0 9.9 ± 8.2 0.493
Maximum hip extension angle − 4.1 ± 14.5 − 2.9 ± 13.9 0.660
Maximum knee flexion angle 60.5 ± 6.4 54.8 ± 9.5 0.001*
Ankle plantarflexion angle at push-off − 12.2 ± 7.4 − 6.5 ± 6.5 0.001*
Ankle plantarflexion angle at initial contact − 3.0 ± 4.3 − 2.6 ± 3.7 0.502
Kinetics
Maximum ankle moment (Nm/kg) 0.9 ± 0.4 0.9 ± 0.4 0.398
Maximum ankle power generation (W/kg) 1.1 ± 0.7 1.3 ± 3.1 0.637
Table 4.  Comparison of postoperative kinetic and kinematic parameters between groups. Negative values 
indicate hip extension and ankle plantarflexion. *P < 0.05.
Parameters Asymptomatic gait Gait disturbance P value
Kinematics (°)
Mean pelvic anterior tilt angle 10.6 ± 6.1 11.6 ± 7.7 0.455
Maximum hip extension angle − 3.8 ± 8.9 0.7 ± 16.2 0.057
Maximum knee flexion angle 62.3 ± 5.4 58.2 ± 9.7 0.004*
Ankle plantarflexion angle at push-off − 12.8 ± 8.2 − 8.3 ± 8.1 0.002*
Ankle plantarflexion angle at initial contact − 3.6 ± 3.9 − 2.7 ± 4.1 0.205
Kinetics
Maximum ankle moment (Nm/kg) 0.9 ± 0.4 0.9 ± 0.3 0.426
Maximum ankle power generation (W/kg) 1.2 ± 6.9 1.1 ± 0.7 0.234
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Discussion
The natural progression of DCM is variable, but typically manifests as a slow, stepwise worsening of 
 symptoms15. Previous studies have addressed the importance of early surgery to obtain substantial postoperative 
Figure 1.  Kinematic graphs of the pelvis, hip, knee, and ankle before and after surgery. Preoperatively, knee 
flexion during the swing phase and ankle plantarflexion at push-off were decreased in the gait disturbance 
group compared to the asymptomatic gait group. These factors improved after surgery, but remained lower than 
in the asymptomatic gait group. In both groups, the ankle angle at initial contact demonstrated plantarflexion 
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 improvement2,13. Early diagnosis is difficult, as DCM is often painless at onset; as a result, DCM may not be diag-
nosed until it progresses to a late stage. Myelopathic gait is one of the DCM  symptoms16, but many patients do not 
also exhibit a definite gait abnormality. Radcliff et al.14 found that 18% of patients with hip fracture manifested 
clinical findings consistent with DCM. Other studies reported an association between myelopathic gait and an 
increased risk of falling or subsequent hip (and other) fragility  fractures17,18. Early detection of gait disturbances 
in DCM is important, not only for better prognosis of DCM after surgery, but also to prevent fractures related 
to the gait disturbance and to maintain the quality of life. In this study, we evaluated the subclinical myelopathic 
gait preoperatively and the improvements of gait abnormalities after surgery.
Previous studies reported reduced ankle plantarflexion and knee ROM as pathologic changes in kinematics, 
with decrease in gait speed and stride length and increase in double-limb support time and step  width4,9,19–22. 
The gait disturbance group in this study also showed less knee and ankle ROM with a declined temporospatial 
parameters compared to the asymptomatic gait group. However, the decrease in knee flexion was not definite in 
the asymptomatic gait group, and the maximum knee flexion did not increase postoperatively. Instead, step width 
and double-limb support duration decreased, and stride length increased with the increase of ankle plantarflexion 
at push-off after surgery only in the asymptomatic gait group. Nagai et al.23 proposed gait speed and stride length 
as indices for evaluating progressive gait abnormalities. Considering the gait parameter improvement in the 
asymptomatic gait group, an increase of step width and double-limb support duration and a reduced stride length 
may be early signs of DCM. However, reduced gait speed or stride length may also reflect a patient’s comfortable 
gait speed, which may be influenced by aging or the patient’s preference. Comparing the gait patterns of people 
with untreated DCM to those of age- and gender-matched healthy controls, Malone et al.5 found that key differ-
ences exist in the motor strategies used in the terminal stance phase of gait (including peak ankle plantarflexion), 
which cannot be explained by speed alone. An increase of step width and double-limb support duration and a 
decrease in ankle push-off at terminal stance indicate early gait deterioration in patients with DCM.
Another abnormal kinematic finding in the asymptomatic gait group was ankle plantarflexion at initial con-
tact. The ankle plantarflexion at initial contact was noted in both groups pre- and postoperatively. This abnormal 
ankle plantarflexion may be misdiagnosed as a foot drop that could be seen in patients with lumbar spinal disease. 
However, patients with foot drop due to weakness in ankle dorsiflexor walk with increased knee flexion for foot 
clearance. In patients with DCM, preoperative knee flexion was decreased, postoperative gait analysis showed 
improved knee flexion and an increase in stable foot clearance with a more powerful push-off demonstrating 
smooth and coordinated movement. Myelopathic gait is classically described as a “spastic pattern gait” and is 
accompanied by hyperreflexia and incoordination of agonist/antagonist  muscles12,24. However, Malone et al.24 
concluded the hyper-excitability of the stretch reflex did not contribute to the abnormal kinetic and kinemat-
ics. They suggested that paresis and poor proprioception were associated with gait impairment. Paresis may be 
related to the decrease of ankle plantarflexion at push-off. Proprioception plays an important role in smooth, 
coordinated activation of the extremities. Sensory information for proprioception is collected at the nerve end-
ings and neural impulses subsequently travel toward the cerebral cortex via the posterior columns of the spinal 
 cord22,25. Any disorder within these neural pathways, such as DCM, can impair proprioception. This may manifest 
as reduced knee flexion during swing phase known as spastic gait. In our opinion, ankle plantarflexion at initial 
contact may be another early sign of spastic gait related to the impaired proprioception.
Improvement in walking speed, step length, and knee ROM have been reported after DCM  surgery11,26. 
Although we observed significant improvements in temporospatial parameters in the asymptomatic gait group, 
the gait disturbance group exhibited no significant improvements in these temporospatial parameters, despite 
improvements in kinetic and kinematic parameters. Furthermore, step width improved only in the asympto-
matic gait group, which was relatively worse in the gait disturbance group postoperatively, although there was 
no difference preoperatively. The importance of early decompressive surgery has been previously  discussed8,12,13. 
Malone et al.12 found no significant changes in temporospatial parameters at 1 year after surgery for DCM. Garza-
Ramos et al.8 concluded that patients with a higher preoperative Nurick grade with symptoms for more than 
12 months may have significantly lower odds of gait improvement after surgery. In our gait disturbance group, 
the average duration of symptoms before surgery was 12.3 months. Furthermore, postoperative parameters in 
the gait disturbance group remained worse than those in the asymptomatic gait group. Early surgery appears 
mandatory for recovery of gait impairment.
Several qualitative functional outcome scales (e.g., JOA score, Nurick grade, European Myelopathy Score, and 
Myelopathy Disability Index scale) have been used clinically to assess the results of DCM surgery. However, in 
addition to having low sensitivity, these outcome scales are subjective, categorical, and overly simplified. In this 
study, lower limb motor function grade according to JOA did not demonstrate a significant change, even though 
the temporospatial parameters in the asymptomatic gait group and kinematic parameters in the gait disturbance 
group were improved. These results suggest that the quantitative assessment of spasticity and deterioration of 
proprioception, based on gait analysis, could play an important role in early detection of gait disturbances in 
patients with DCM, as well as in the assessment of postoperative improvements. Decompressive surgery after 
early detection of DCM is expected to reduce complications associated with gait disturbances, such as fragility 
fractures, and improve the patients’ quality of life.
This study had several limitations. First, it had a retrospective design, and the operative methods differed 
between anterior and posterior decompression procedures. However, the surgical approach and the duration 
of symptoms were not significantly different between the asymptomatic gait and gait disturbance groups. Sec-
ond, we only selected patients who could walk at least 20 m on their own; therefore, patients with severe gait 
disturbance or those who could only walk with an assistive device were not evaluated. Even when the patients 
are non-ambulatory, improved walking ability may be observed after  surgery13. In this study, there was no 
significant improvement in the temporospatial parameters of the gait disturbance group; therefore, other study 
protocol besides the gait analysis should be added for the severely affected patients in the future. Finally, we set 
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the end-point of postoperative improvement at 6 months considering the presence of other degenerative dis-
eases, such as osteoarthritis or spinal stenosis, in this elderly population. This follow-up period was also based 
on previous studies 26,27. A prospective study involving a larger number of patients (including non-ambulatory 
patients) and a longer follow-up period would be helpful to further understand the potential improvements in 
myelopathic gait after DCM surgery.
In conclusion, reduced ankle plantarflexion angle at push-off, increased step width, and increased double-
limb support duration may be early signs of DCM. Ankle plantarflexion at initial contact may also indicate early 
gait deterioration in patients with DCM. Even the patients without gait disability can be benefited from surgery 
in terms of the temporospatial parameter improvement. In the gait disturbance group, knee ROM and ankle 
plantarflexion at push-off improved after surgery, but were still lower compared to the asymptomatic gait group. 
Furthermore, preoperatively declined temporospatial parameters did not improve. Early diagnosis and surgery 
for DCM may be essential for preserving gait function and improving gait disability.
Methods
Study design and materials. This retrospective study was approved by the Asan Medical Center Insti-
tutional Review Board, and was conducted in accordance with the Declaration of Helsinki. Informed consent 
waiver was obtained from the Asan Medical Center Institutional Review Board (2020–1030). We reviewed the 
patients who had undergone decompressive surgery for DCM by a single surgeon (D.H.L) between 2014 and 
2016. The following inclusion criteria were applied in this study: (1) aged 18 years and older, (2) clinical and radi-
ological evidence of DCM, (3) able to walk at least 20 m without assistance from another person or a walking aid, 
and (4) availability of complete preoperative and postoperative three-dimensional gait analysis. Patients were 
excluded if they had thoracic or lumbar spinal disease, as well as other conditions that may affect their walking 
ability (e.g., leg length discrepancy more than 2 cm, degenerative or rheumatoid osteoarthritis, peripheral nerve 
disease or injury, stiff joint, cardiac disease, respiratory disease, stroke, traumatic brain injury, and myelitis), or 
had a history of orthopedic surgery or neurosurgery that could affect gait. Sixty-two patients (46 males and 16 
females) with a mean age of 58.6 years (range 42 to 76 years) were included in this study.
Since gait analysis was impossible to determine for patients who could not walk independently, all of the 
included patients had their lower limb motor function graded as 2, 3, or 4, according to the Japanese Orthopedic 
Association (JOA). Patients with grade 4 (“normal”) were classified as the asymptomatic gait group (n = 30), and 
those with grade 3 [“possible to walk without cane or aid, but slow” (n = 17)] or grade 2 [“need cane or aid only 
on stairs” (n = 15)] were combined and classified as the gait disturbance group (n = 32).
Gait analysis protocol. Gait analysis was performed on a flat-ground, 20-m track using a computerized 
three-dimensional gait analysis system consisting of six infrared cameras (Motion Analysis®, Santa Rosa, CA, 
USA). Fifteen retroreflective markers were attached to anatomical landmarks using the Modified Helen Hayes 
method. The capture volume of the cameras was calibrated prior to each assessment to achieve calibration resid-
uals less than 2.5 mm. Anthropometric data were collected according to a standard protocol. After a warm-up 
trial, individuals walked continuously and freely along the track five times. Participants were permitted to rest 
between trials to avoid fatigue. Two force-plates, located under the path, recorded ground reaction forces dur-
ing walking, and joint moments were expressed as internal moments to counter the ground reaction force. 
Kinematic data was shown as the angle between two segment axes projected into the each sagittal, coronal, and 
transverse plane. The gait cycle events (heel strike and toe off) were identified automatically from the force plate 
data during walking. The kinematic and kinetic data were derived for pelvis, hip, knee, and ankle in three planes.
The following parameters from kinematic and kinetic data were analyzed: temporospatial parameters (step 
width, stride length, velocity, standing phase duration, and double-limb support duration), kinematic parameters 
(mean pelvic anterior tilt, maximum hip extension angle, maximum knee flexion angle, ankle plantarflexion angle 
at push-off, and ankle plantarflexion angle at initial contact), and kinetic parameters (maximum ankle moment 
and maximum ankle power generation).
Gait analysis was performed before surgery and at 6 months after surgery. This postoperative period was a 
compromise between increasing the likelihood of optimal surgical recovery and reducing the potential confound-
ing effects of aging and degenerative joint disease during follow-up27.
Statistical analysis. Statistical analysis was performed using the SPSS version 23 (IBM Corp, Armonk, 
NY). Independent t-tests were used to compare the parameters between asymptomatic gait and gait disturbance 
groups, and paired t-tests were used to compare the parameters between preoperative and postoperative evalua-
tions. Values are presented as mean and ranges. The statistical significance level was set at P < 0.05.
Ethical approval. This study was approved by the Asan Medical Center Institutional Review Board (IRB 
No. 2020-1030).
Data availability
The datasets generated during and/or analyzed in the current study are available from the corresponding author 
upon reasonable request.
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